Published in Neurology on August 12, 2003
Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology (2013) 2.79
Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc (2009) 2.34
Crohn's disease is associated with restless legs syndrome. Inflamm Bowel Dis (2010) 1.66
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A (2004) 1.59
Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion (2013) 1.53
Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain (2009) 1.53
Profile of altered brain iron acquisition in restless legs syndrome. Brain (2011) 1.48
Ferritin for the clinician. Blood Rev (2008) 1.46
Midlife migraine and late-life parkinsonism: AGES-Reykjavik study. Neurology (2014) 1.44
Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol (2011) 1.32
Neuroimaging insights into the pathophysiology of sleep disorders. Sleep (2008) 1.31
Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet (2004) 1.18
Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene (2010) 1.17
A delicate balance: Iron metabolism and diseases of the brain. Front Aging Neurosci (2013) 1.11
Association between sleep disorders, obesity, and exercise: a review. Nat Sci Sleep (2013) 1.10
Sensory aspects of movement disorders. Lancet Neurol (2014) 1.09
Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med (2008) 1.04
Iron for restless legs syndrome. Cochrane Database Syst Rev (2012) 1.02
Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol (2008) 1.01
Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci (2009) 0.99
A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med (2008) 0.99
Systems genetic analysis of the effects of iron deficiency in mouse brain. Neurogenetics (2012) 0.98
Mitochondrial ferritin in the substantia nigra in restless legs syndrome. J Neuropathol Exp Neurol (2009) 0.97
The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep (2011) 0.96
The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal. Sleep Med (2009) 0.96
Diurnal cycle influences peripheral and brain iron levels in mice. J Appl Physiol (1985) (2008) 0.93
Ropinirole for the treatment of restless legs syndrome. Neuropsychiatr Dis Treat (2006) 0.90
Sleep disturbances associated with Parkinson's disease. Parkinsons Dis (2011) 0.90
Restless legs syndrome presenting as an acute exacerbation of multiple sclerosis. Mult Scler Int (2011) 0.90
Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. Sleep (2008) 0.89
The biopsychosocial effects of restless legs syndrome (RLS). Neuropsychiatr Dis Treat (2006) 0.89
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J Neural Transm (Vienna) (2006) 0.89
Systems genetics analysis of iron regulation in the brain. Biochimie (2009) 0.89
Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep (2013) 0.87
Perspective on sleep and aging. Front Neurol (2010) 0.86
Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Neuroscience (2013) 0.85
Possible association between vitamin D deficiency and restless legs syndrome. Neuropsychiatr Dis Treat (2014) 0.82
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome. Medicine (Baltimore) (2015) 0.82
Restless Legs Syndrome: Would You Like That with Movements or Without? Tremor Other Hyperkinet Mov (N Y) (2015) 0.82
Animal models of sleep disorders. Comp Med (2013) 0.82
Restless legs syndrome as a comorbidity in rheumatoid arthritis. Autoimmune Dis (2013) 0.82
An emerging role for Cullin-3 mediated ubiquitination in sleep and circadian rhythm: insights from Drosophila. Fly (Austin) (2013) 0.81
Normal regional brain iron concentration in restless legs syndrome measured by MRI. Nat Sci Sleep (2009) 0.81
Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells. Exp Neurol (2008) 0.81
T2 relaxometry using 3.0-tesla magnetic resonance imaging of the brain in early- and late-onset restless legs syndrome. J Clin Neurol (2014) 0.80
Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. Fluids Barriers CNS (2013) 0.79
The association of Restless Legs Syndrome with hypertension and cardiovascular disease. Med Sci Monit (2014) 0.79
Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism. Curr HIV Res (2012) 0.79
Association of restless legs syndrome variants in Korean patients with restless legs syndrome. Sleep (2013) 0.78
Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. J Neurol (2017) 0.78
Low brain iron effects and reversibility on striatal dopamine dynamics. Exp Neurol (2014) 0.77
In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study. J Cereb Blood Flow Metab (2012) 0.77
Brain Iron Metabolism Dysfunction in Parkinson's Disease. Mol Neurobiol (2016) 0.77
Restless legs syndrome: differential diagnosis and management with rotigotine. Neuropsychiatr Dis Treat (2009) 0.77
Parkinson's Disease: The Mitochondria-Iron Link. Parkinsons Dis (2016) 0.76
A comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndrome. Med Devices (Auckl) (2015) 0.76
Relationship of serum ferritin level and tic severity in children with Tourette syndrome. Childs Nerv Syst (2017) 0.75
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. Sleep (2016) 0.75
Restless Legs Syndrome: Current Concepts about Disease Pathophysiology. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
Iron and restless legs syndrome: treatment, genetics and pathophysiology. Sleep Med (2016) 0.75
Ropinirole in restless legs syndrome and periodic limb movement disorder. Ther Clin Risk Manag (2010) 0.75
Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation. Sleep Med (2016) 0.75
Update on the management of restless legs syndrome: existing and emerging treatment options. Nat Sci Sleep (2010) 0.75
[The restless legs syndrome: incidence and risk factors in hemodialysis]. Pan Afr Med J (2015) 0.75
A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis. Ther Adv Neurol Disord (2015) 0.75
Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla. Sleep Med (2016) 0.75
Parkinson disease: an update. Neurologist (2004) 0.75
Sleep-related movement disorders. Neurol Sci (2011) 0.75
Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management. Front Aging Neurosci (2017) 0.75
[Iron deficiency, Fatigue and Restless-Legs-Syndrome]. Wien Med Wochenschr (2016) 0.75
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). X. THE TREATMENT OF ACUTE SYSTEMIC MERCURY POISONING IN EXPERIMENTAL ANIMALS WITH BAL, THIOSORBITOL AND BAL GLUCOSIDE. J Clin Invest (1946) 3.04
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
Pregnancy and the risk of stroke. N Engl J Med (1996) 2.68
Outbreak of clinical mastitis in dairy cows following 'blitz' therapy. Vet Rec (1997) 2.63
Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology (2008) 2.51
Relationship of iron to oligodendrocytes and myelination. Glia (1996) 2.44
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36
Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis (1983) 2.18
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16
Quinoid redox cycling as a mechanism for sustained free radical generation by inhaled airborne particulate matter. Free Radic Biol Med (2001) 1.96
Iron and the restless legs syndrome. Sleep (1998) 1.87
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology (2000) 1.75
MRI measurement of brain iron in patients with restless legs syndrome. Neurology (2001) 1.75
Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology (1998) 1.75
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res (1992) 1.69
Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation (1998) 1.65
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res (1990) 1.60
Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol (2001) 1.53
Medication use in patients with restless legs syndrome compared with a control population. Eur J Neurol (2007) 1.46
Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology (2000) 1.45
Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology (2011) 1.42
Survival of patients undergoing Nd:YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease. Chest (1993) 1.42
Nd:YAG laser bronchoscopy. Rigid or fiberoptic mode? Chest (1990) 1.39
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res (2001) 1.38
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol (1993) 1.31
Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology (2004) 1.28
Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet (2000) 1.27
The extrapleural air sign in pneumomediastinum. Radiology (1965) 1.26
Insight into the pathophysiology of restless legs syndrome. J Neurosci Res (2000) 1.26
Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep (1996) 1.23
The role of coronary artery injury and perfusion in the development of cardiac contusion secondary to nonpenetrating chest trauma. J Trauma (1979) 1.22
Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res (2005) 1.22
A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain (1999) 1.22
Neonatal small left colon syndrome. Am J Roentgenol Radium Ther Nucl Med (1974) 1.21
Iron and iron management proteins in neurobiology. Pediatr Neurol (2001) 1.18
Cellular management of iron in the brain. J Neurol Sci (1995) 1.11
The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis (1983) 1.09
Altered cellular distribution of iron in the central nervous system of myelin deficient rats. Neuroscience (1990) 1.08
Growth rebound after termination of stimulant drugs. J Pediatr (1975) 1.06
Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience (1999) 1.03
Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology (1998) 1.01
Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation. Qual Life Res (2004) 1.00
Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res (1994) 0.99
X-ray spectroscopic studies of the high temperature reduction of Cu(II)O by 2-chlorophenol on a simulated fly ash surface. Environ Sci Technol (2003) 0.99
Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol (1997) 0.97
Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics (1973) 0.97
Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res (1999) 0.97
Homocyst(e)ine and risk of cerebral infarction in a biracial population : the stroke prevention in young women study. Stroke (1999) 0.95
A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol (1995) 0.95
Carotid arterial stiffness as a surrogate for aortic stiffness: relationship between carotid artery pressure-strain elastic modulus and aortic pulse wave velocity. Ultrasound Med Biol (1999) 0.94
A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep (1993) 0.94
Rib gap defects with micrognathia. The cerebro-costo-mandibular syndrome--a Pierre Robin-like syndrome with rib dysplasia. Am J Roentgenol Radium Ther Nucl Med (1972) 0.92
Family history study of the restless legs syndrome. Sleep Med (2002) 0.92
The central effects of scopolamine in man. Biol Psychiatry (1971) 0.92
Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case report and review of the literature. J Neurosurg (2000) 0.92
Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology (1998) 0.91
A phase I study of active specific intralymphatic immunotherapy (ASILI). Cancer (1978) 0.91
Influence of age and postmenopausal estrogen replacement therapy on carotid arterial stiffness in women. Cardiovasc Res (1999) 0.90
Molecular products and radicals from pyrolysis of lignin. Environ Sci Technol (2012) 0.90
CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord (2001) 0.90
Slow wave sleep changes: alcohol tolerance and treatment implications. Adv Exp Med Biol (1977) 0.90
Molecular modeling studies of the reactions of phenoxy radical dimers: pathways to dibenzofurans. J Phys Chem A (2005) 0.89
Androgenic involvement in conditioned taste aversion. Horm Behav (1978) 0.89
Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology (2002) 0.89
Evaluation of erectile function in men with sickle cell disease. Urology (1995) 0.89
Alcohol intake, type of beverage, and the risk of cerebral infarction in young women. Stroke (2001) 0.88
Abnormal inspiratory flow-volume curves in patients with sleep-disordered breathing. Am Rev Respir Dis (1981) 0.88
Recurrent pulmonary emboli secondary to right atrial thrombus around a permanent pacing catheter: a case report and review of the literature. Pacing Clin Electrophysiol (1979) 0.88
Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep (1996) 0.88
A motivational environment for behaviorally deviant junior high school students. J Abnorm Child Psychol (1976) 0.88
Accessory diaphragm. Duplication of the diaphragm. Radiol Clin North Am (1968) 0.88
Effects of alcohol ingestion and abstinence on slow wave sleep of alcoholics. Adv Exp Med Biol (1975) 0.87
alpha-Fetoprotein: studies of tumor-associated antigen cytotoxicity in mouse hepatoma BW7756. Clin Immunol Immunopathol (1978) 0.87
In vitro hypoxia and excitotoxicity in human brain induce calcineurin-Bcl-2 interactions. Neuroscience (2003) 0.87
Do sleep patterns relate to the desire for alcohol? Adv Exp Med Biol (1975) 0.87
CT demonstration of pharyngeal narrowing in adult obstructive sleep apnea. AJR Am J Roentgenol (1983) 0.86
The characteristics of alcoholics frequently lost to follow-up. J Stud Alcohol (1987) 0.86
Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol (1996) 0.86
Effects of prior exposure on conditioned taste aversion in the rat: androgen- and estrogen-dependent events. J Comp Physiol Psychol (1979) 0.86
Distribution and correlates of elevated total homocyst(e)ine: the Stroke Prevention in Young Women Study. Ann Epidemiol (1999) 0.86
Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke (1998) 0.85
Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Neuroscience (2013) 0.85
Alpha fetoprotein: effect of heterologous antiserum on hepatoma cells in vitro. J Natl Cancer Inst (1975) 0.84
Pressure controlled inverse ratio ventilation in severe adult respiratory failure. Chest (1988) 0.84
Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors. J Immunol (1976) 0.84
Of mice and men, periodic limb movements and iron: how the human genome informs the mouse genome. Genes Brain Behav (2008) 0.84
Residual effects of ethanol and chlordiazepoxide treatments for alcohol withdrawal. J Nerv Ment Dis (1978) 0.84
Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol (1998) 0.84
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology (2003) 0.83
Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J Infect Dis (1999) 0.83